Publications by authors named "Felix Deanda"

Claim this Profile
B
Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling.
Wei Li, Renata Sano, Mutiah Apatira, Felix DeAnda, Tarikere Gururaja

Mol Cancer Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK.
Kamaldeep Dhami, Anirban Chakraborty, Tarikere L Gururaja, Leo W-K Cheung, Chaohong Sun, Felix DeAnda

Sci Signal· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics.
Felix DeAnda, Kendra E Hightower, Robert T Nolte, Kazunari Hattori, Tomokazu Yoshinaga

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.
Greg L Beilhartz, Marianne Ngure, Brian A Johns, Felix DeAnda, Peter Gerondelis

J Biol Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalent polymorphisms in wild-type HIV-1 integrase are unlikely to engender drug resistance to dolutegravir (S/GSK1349572).
Cindy Vavro, Samiul Hasan, Heather Madsen, Joseph Horton, Felix DeAnda

Antimicrob Agents Chemother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats.
Maosheng Duan, Wieslaw M Kazmierski, Pek Y Chong, Felix Deanda, Mark Edelstein

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir (S/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes.
Kendra E Hightower, Ruolan Wang, Felix Deanda, Brian A Johns, Kurt Weaver

Antimicrob Agents Chemother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
Samarjit Patnaik, Kirk L Stevens, Roseanne Gerding, Felix Deanda, J Brad Shotwell

Bioorg Med Chem Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase.
Stanley D Chamberlain, Joseph W Wilson, Felix Deanda, Samarjit Patnaik, Anikó M Redman

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
Stanley D Chamberlain, Anikó M Redman, Joseph W Wilson, Felix Deanda, J Brad Shotwell

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.
Stanley D Chamberlain, Anikó M Redman, Samarjit Patnaik, Keith Brickhouse, Yen-Chiat Chew, Felix Deanda

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinase-targeted library design through the application of the PharmPrint methodology.
Felix Deanda, Eugene L Stewart, Michael J Reno, David H Drewry

J Chem Inf Model· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1.
Wieslaw M Kazmierski, Christopher Aquino, Brian A Chauder, Felix Deanda, Robert Ferris

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aza-stilbenes as potent and selective c-RAF inhibitors.
Octerloney McDonald, Karen Lackey, Ronda Davis-Ward, Edgar Wood, Vicente Samano, Felix Deanda

Bioorg Med Chem Lett· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the PharmPrint methodology to two protein kinases.
Felix Deanda, Eugene L Stewart

J Chem Inf Comput Sci· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSSI, a general model for solute-solvent interactions. 1. Description of the model.
Felix Deanda, Karl M Smith, Jie Liu, Robert S Pearlman

Mol Pharm· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors.
Wieslaw Kazmierski, Neil Bifulco, Hanbiao Yang, Larry Boone, Felix DeAnda

Bioorg Med Chem· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach for identifying the surface atoms of macromolecules.
Felix Deanda, Robert S Pearlman

J Mol Graph Model· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis